secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2021-08-04T23:59:59+00:00
Accession:  0001104659-21-100070
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast Q2 2021 revenue $394.2M (+79% YoY), EPS $3.96; FY guidance $1.425-1.525B
--------------------------------------------------------------------------------

- Revenue $394.2M, up 79.2% YoY; net income $47M (+114.1%); diluted EPS $3.96 (+112.9%).
- Active OPTA VIA coaches 59,200 (+62.2%); revenue per coach $6,662 (+13.9%).
- Gross margin 74.5% vs 72.4%; operating income $61.4M, up 118.5%
- FY2021 guidance: revenue $1.425-1.525B, EPS $12.70-14.17.
- Declared $1.42/sh dividend (pay Aug 6); $12.2M share repurchases; $125M credit facility undrawn.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000110465921100070/0001104659-21-100070-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000110465921100070/tm2124088d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-100070

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer